Subcutaneous ICDs Take Care of Lead Complications in ATLAS Trial - Medpage Today
5/3/2022 12:00:00 AM3 years 10 months ago
by Nicole Lou
by Nicole Lou
But do they perform as well as standard transvenous ICDs?
SAN FRANCISCO -- Candidates for an implantable cardioverter-defibrillator (ICD) found that a subcutaneous device dramatically slashed the major lead-related complications seen with transvenous device… [+3833 chars]
full article...